Show simple item record

dc.contributor.authorBenhalima, Katrien
dc.contributor.authorMathieu, Chantal
dc.contributor.authorDamm, Peter
dc.contributor.authorVan Assche, André
dc.contributor.authorDevlieger, Roland
dc.contributor.authorDesoye, Gernot
dc.contributor.authorCorcoy, Rosa
dc.contributor.authorMahmood, Tahir
dc.contributor.authorNizard, Jacky
dc.contributor.authorSavona-Ventura, Charles
dc.contributor.authorDunne, Fidelma
dc.date.accessioned2018-09-20T16:00:52Z
dc.date.available2018-09-20T16:00:52Z
dc.date.issued2015-05-08
dc.identifier.citationBenhalima, Katrien; Mathieu, Chantal; Damm, Peter; Van Assche, André; Devlieger, Roland; Desoye, Gernot; Corcoy, Rosa; Mahmood, Tahir; Nizard, Jacky; Savona-Ventura, Charles; Dunne, Fidelma (2015). A proposal for the use of uniform diagnostic criteria for gestational diabetes in europe: an opinion paper by the european board & college of obstetrics and gynaecology (ebcog). Diabetologia 58 (7), 1422-1429
dc.identifier.issn0012-186X,1432-0428
dc.identifier.urihttp://hdl.handle.net/10379/10404
dc.description.abstractScreening and diagnostic criteria for gestational diabetes (GDM) are inconsistent across Europe, and the development of a uniform GDM screening strategy is necessary. Such a strategy would create opportunities for more women to receive timely treatment for GDM. Developing a consensus on screening for GDM in Europe is challenging, as populations are diverse and healthcare delivery systems also differ. The European Board & College of Obstetrics and Gynaecology (EBCOG) has responded to this challenge by appointing a steering committee, including members of the EBCOG and the Diabetic Pregnancy Study Group (DPSG) associated with the EASD, to develop a proposal for the use of uniform diagnostic criteria for GDM in Europe. A proposal has been developed and has now been approved by the Council of the EBCOG. The current proposal is to screen for overt diabetes at the first prenatal contact using cut-off values for diabetes outside pregnancy, with particular efforts made to screen high-risk groups. When screening for GDM is performed at 24 weeks' gestation or later, the proposal is now to use the 75 g OGTT with the new WHO diagnostic criteria for GDM. However, more research is necessary to evaluate the best GDM screening strategy for different populations in Europe. Therefore, no clear recommendation has been made on whether a universal one-step, two-step or a risk-factor-based screening approach should be used. The use of the same WHO diagnostic GDM criteria across Europe will be an important step towards uniformity.
dc.publisherSpringer Nature
dc.relation.ispartofDiabetologia
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Ireland
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/3.0/ie/
dc.subjectdiagnostic criteria
dc.subjectgestational diabetes
dc.subjectproposal
dc.subjectscreening
dc.subjectadverse pregnancy outcomes
dc.subjectfasting plasma-glucose
dc.subjectinternational association
dc.subjecttolerance test
dc.subjectmellitus
dc.subjecthyperglycemia
dc.subjectwomen
dc.subjectprevalence
dc.subjectchina
dc.subjectrecommendations
dc.titleA proposal for the use of uniform diagnostic criteria for gestational diabetes in europe: an opinion paper by the european board & college of obstetrics and gynaecology (ebcog)
dc.typeArticle
dc.identifier.doi10.1007/s00125-015-3615-7
dc.local.publishedsourcehttps://link.springer.com/content/pdf/10.1007%2Fs00125-015-3615-7.pdf
nui.item.downloads0


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Ireland
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Ireland